Thermo Fisher (TMO) Agrees to Acquire Brahms for $470M

Ben Zinga

September 03, 2009 9:30am Comments

Thermo Fisher Scientific Inc (NYSE: TMO) has agreed to acquire German disease diagnostics firm Brahms, for $470M. Thermo Fisher expects the deal to add to its earnings per share in 2010. Brahms, which makes diagnostic tests used by laboratories, generated revenue of about $105 million in 2008.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: M&A News

1	FTNT, EXEL: US Stocks Set To Open Higher After Monday's Crash, VIX Plummets:...
2	NVRO, CYRX: Why Fortinet Shares Are Trading Higher By Around 17%; Here A...
3	IEMG, GXC: Japan's Nikkei Lifts Asia, Europe Gains; Crude...
4	LUMN: What's Going On With Lumen Technologies Stock?
5	CG: Carlyle Q2 Earnings: Taking a Look at Key Met...
6	AGRI, HPAI: Why Palantir Technologies Shares Ar...
7	VREOF: Vireo Growth Inc. Turns $1M Lo...

1	LPX: Louisiana-Pacific's Q2 Net Sales Skyrocket: 'Notching Another Recor...
2	Brent Oil Price Analysis: Anticipating A Correction
3	H: Hyatt Hotels Analysts Cut Their Forecasts Following Q2 Results
4	DSNKY, NVDA: Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This...
5	$ETH, $BTC: Kamala Harris VP Pick Tim Walz Draws Mixed Reactions Fr...
6	Peter Thiel Launched J.D. Vance's Venture Capital...
7	SHOP: Shopify's Q2 Earnings: Revenue And EPS Beat, G...

Market Overview

Tickers

Articles

Keywords

Thermo Fisher (TMO) Agrees to Acquire Brahms for $470M

Related Articles (TMO)